Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cefpodoxime proxetil 50mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefpodoxime proxetil 100mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefpodoxime 40mg/5mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet |
Has precise active ingredient |
True |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 8 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cefpodoxime proxetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |